Physician

Apoorva Chawla, M.D.

According to 2025 Medicare claims, Apoorva Chawla, M.D. (NPI: 1710114145) practices medical oncology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1144217894; TIN: 340936207) and primary practice location at 43623-3536. Chawla is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Chawla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 278 traditional Medicare patients, billed 28,915 HCPCS/CPT codes, and received $408,010 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 705 prescription claims across 128 beneficiaries totaling $1,259,686 in drug costs, led by Ayvakit (Avapritinib). 2023 DME data shows 28 claims. Open Payments data shows 52 records totaling $1,214. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $110,701 to $408,010. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $39,798 and ending at $1,259,686. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,172 and ending at $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	138	12,831	$110,701
2016	310	96,787	$801,416
2017	437	109,748	$1,505,816
2018	494	121,414	$1,772,393
2019	498	176,822	$2,736,392
2020	582	200,472	$3,837,809
2021	569	156,677	$2,712,862
2022	525	103,650	$1,764,251
2023	322	25,700	$422,267
2024	278	28,915	$408,010

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	123	$39,798
2016	74	497	$453,332
2017	144	655	$711,615
2018	156	850	$1,496,054
2019	170	1,002	$1,758,025
2020	198	1,273	$3,555,292
2021	194	1,189	$3,185,967
2022	155	868	$2,313,282
2023	150	427	$369,137
2024	128	705	$1,259,686

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$3,069
2017	N/R	99	$15,775
2018	N/R	92	$11,503
2019	N/R	109	$12,520
2020	11	124	$12,398
2021	N/R	95	$8,807
2022	N/R	82	$2,738
2023	N/R	28	$4,694
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	40	40	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	61	94	$127
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	57	57	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	177	403	$84
96372	Injection of drug or substance under skin or into muscle	28	39	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ayvakit	Avapritinib	11	330	$422,908
Nubeqa	Darolutamide	12	360	$166,147
Eliquis	Apixaban	37	1,170	$22,177
Hydroxyurea	Hydroxyurea	42	2,412	$677
Prochlorperazine Maleate	Prochlorperazine Maleate	39	571	$618

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,214	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Apoorva Chawla, M.D.?

Tedicare shows public-source Medicare data for Apoorva Chawla, M.D. (NPI 1710114145), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Apoorva Chawla, M.D. have ACO affiliation data?

Apoorva Chawla, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Apoorva Chawla, M.D.?

Apoorva Chawla, M.D. is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1144217894) in the available physician profile data.

Does Apoorva Chawla, M.D. have Open Payments data?

Apoorva Chawla, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.